DBV TECHNOLOGIES

Serial Number 79364819
Registration 7390033
700

Registration Progress

Application Filed
Sep 19, 2022
Under Examination
Approved for Publication
Feb 14, 2024
Published for Opposition
Mar 5, 2024
Registered
May 21, 2024

Trademark Image

DBV TECHNOLOGIES

Basic Information

Serial Number
79364819
Registration Number
7390033
Filing Date
September 19, 2022
Registration Date
May 21, 2024
Published for Opposition
March 5, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 21, 2024
Registration
Registered
Classes
005 010 041 042
+1 more

Rights Holder

DBV TECHNOLOGIES

98
Address
Bâtiment IRO,
107 Av. de la République F-92320 Châtillon
FR

Ownership History

DBV TECHNOLOGIES

Original Applicant
33
FR

DBV TECHNOLOGIES

Owner at Publication
33
FR

DBV TECHNOLOGIES

Original Registrant
33
FR

DBV TECHNOLOGIES

New Owner After Registration #1
98
FR

Legal Representation

Attorney
Jennifer Sheehan Anderson

USPTO Deadlines

Next Deadline
1757 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-05-21)
Due Date
May 21, 2030
Grace Period Ends
November 21, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description Documents
Nov 30, 2024 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Nov 9, 2024 FIMP P FINAL DISPOSITION PROCESSED Loading...
Nov 9, 2024 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Aug 21, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jul 13, 2024 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Jun 15, 2024 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
May 21, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 21, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 5, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 5, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 4, 2024 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Feb 14, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 14, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 14, 2024 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Feb 14, 2024 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Jan 26, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 24, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 24, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 24, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 29, 2023 RFNT P REFUSAL PROCESSED BY IB Loading...
Aug 9, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Aug 9, 2023 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jul 5, 2023 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jul 4, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 29, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 21, 2023 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Mar 17, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 9, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Medicated adhesive devices in the nature of epicutaneous patches enabling the cutaneous or epicutaneous administration of pharmaceutical or medicated substances in dry form for humans and animals for the treatment and prevention of allergies, autoimmune, inflammatory and infectious diseases; epicutaneous patches containing powdered preparations for medical use for the treatment and prevention of allergies, autoimmune, inflammatory and infectious diseases; medicated occlusion patches in the nature of epicutaneous patches enabling the absorption of powdered medicated substances through the skin for the treatment and prevention of allergies, autoimmune, inflammatory and infectious diseases
Class 010
Medical apparatus, instruments and devices, namely, epicutaneous patches sold without medication for the cutaneous or epicutaneous administration of medicated or cosmetic substances in dry form for humans or animals; occlusion patch dispensers for medical use; medical instruments using the electrostatic properties of biocompatible media, namely, epicutaneous patches sold without medication
Class 041
Educational services for consumers and professionals in the field of immunotherapy, namely, organizing classes, seminars, programs, conferences, congresses, workshops in the field of immunotherapy; organizing and providing exhibitions for online educational purposes featuring interactive presentations and exhibitions in the field of immunotherapy; publishing periodicals, books, and guides in the field of immunotherapy; database publishing services, namely publishing of periodical journals containing printed databases in tabular form in the field of immunotherapy; providing information with respect to education in the field of immunotherapy via an online website
Class 042
Medical and scientific research in the field of immunotherapy, namely, developing scientific methods for epicutaneous immunotherapy, to try to treat and prevent autoimmune, infectious and inflammatory diseases without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact; scientific research in the field of allergy treatment and care; scientific research in the field of allergy treatment for the repeated application of treatments to patients' skin without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact and thus avoid the passage of allergens into the blood; allergenic drug discovery services; medical and scientific research services, namely, developing methods for treating allergies via contact between allergens and skin immune cells; medical and scientific research services, namely, developing methods for the treatment and prevention of allergies, autoimmune, infectious and inflammatory diseases by applying patches to patients' unbroken skin without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact
Class 044
Medical services using desensitization methods on the principle of immunotherapy; medical treatment and prevention of allergies, inflammatory, autoimmune and infectious diseases through the administration of allergens, antigens using patches affixed to the patients' unbroken skin, thus avoiding the transfer of allergens into the blood; medical treatment and prevention of allergies, inflammatory, autoimmune and infectious diseases using epicutaneous methods of desensitization via immunotherapy; epicutaneous medical treatments and prevention of allergies, inflammatory, autoimmune and infectious diseases without prior preparation of the skin other than a simple rapid cleaning in order to leave the cell structure of the skin intact; medical consultancy in the field of desensitization to allergies with respect to desensitization to combat allergies

Classification

International Classes
005 010 041 042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"TECHNOLOGIES"